Publication | Closed Access
Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.
91
Citations
12
References
1995
Year
At the doses and schedules used in this study, IFN affords no benefit to 5-FU in terms of response and survival and significantly increases toxicity for patients with advanced colorectal cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1